
Erlotad 150 Tablet
Marketer
Adley Formulations
Salt Composition
Erlotinib (150mg)
Overview Erlotad 150 Tablet
Erlotad 150mg tablets are indicated for treating non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or at least one hour before or two hours after a meal. Continue taking it as directed by your physician; treatment duration depends on individual response and needs. Strictly adhere to your doctor's prescribed dosage; incorrect or excessive use may lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; do not discontinue use without your doctor's consent. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity is possible; protective clothing and sunscreen are recommended outdoors. Report mouth sores, vision changes, or breathing problems to your doctor immediately. Regular liver function monitoring may be advised. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Effective contraception for both partners is crucial during treatment to prevent pregnancy. Smoking cessation is recommended as it can interfere with the drug's efficacy. Maintain a minimum two-hour interval between Erlotad 150mg and antacids or other medications.
Uses of Erlotad 150 Tablet
Cancers of the pancreas and non-small-cell lung
Major Benefits of Erlotad 150 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Erlotad 150mg tablets should be taken on an empty stomach.
Common Side effects of Erlotad 150 Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlotad 150 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erlotad 150 Tablet on an empty stomach.
How Erlotad 150 Tablet works:
Erlotad 150mg tablets are a cancer treatment. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to these EGFRs, thereby blocking the cancer-promoting signals they transmit and limiting tumor expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlotad 150 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Erlotad 150 Tablet during pregnancy is contraindicated due to established risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use acceptable if the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Erlotad 150 Tablet is likely inadvisable. Available human data indicates potential transfer of the medication to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Erlotad 150 Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Erlotad 150 Tablets are considered safe for patients with kidney impairment; dosage modification is unnecessary. However, its use is contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Erlotad 150mg tablets; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erlotad 150 Tablet :
Omit any missed Erlotad 150 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Erlotad 150 Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
